1
|
Alashkar Alhamwe B, Yuskaeva K, Wulf F, Trinkmann F, Kriegsmann M, Thomas M, Keber CU, Strandmann EPV, Herth FJ, Kolahian S, Renz H, Muley T. Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC. Int J Mol Sci 2024; 25:9552. [PMID: 39273499 PMCID: PMC11395097 DOI: 10.3390/ijms25179552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 08/20/2024] [Accepted: 08/26/2024] [Indexed: 09/15/2024] Open
Abstract
Immune activation status determines non-small cell lung cancer (NSCLC) prognosis, with reported positive/negative associations for T helper type 2 (TH2) responses, including allergen-specific IgE and eosinophils. Our study seeks to explore the potential impact of these comorbid immune responses on the survival rates of patients with NSCLC. Our retrospective study used data from the Data Warehouse of the German Center for Lung Research (DZL) and Lung Biobank at Thoraxklinik Heidelberg. We estimated the association of blood eosinophilia and neutrophilia on survival rates in an inflammatory cohort of 3143 patients with NSCLC. We also tested sensitization to food and inhalants and high-sensitivity C-reactive protein (hs-CRP) in a comorbidity cohort of 212 patients with NSCLC. Finally, we estimated the infiltration of immune-relevant cells including eosinophils, T-cells, and mast cells in a tissue inflammatory sub-cohort of 60 patients with NSCLC. Sensitization to at least one food or inhalant (sIgE) was higher in patients with adenocarcinoma (adeno-LC) than the non-adenocarcinoma (non-adeno-LC). Furthermore, hs-CRP was higher in non-adeno-LC compared with adeno-LC. Peripheral inflammation, particularly eosinophilia and neutrophilia, was associated with poor survival outcomes in NSCLC with a clear difference between histological subgroups. Finally, blood eosinophilia was paralleled by significant eosinophil infiltration into the peritumoral tissue in the lung. This study provides novel perspectives on the crucial role of peripheral inflammation, featuring eosinophilia and neutrophilia, with overall survival, underscoring distinctions between NSCLC subgroups (adeno-LC vs. non-adeno-LC). Peripheral eosinophilia enhances eosinophil infiltration into tumors. This sheds light on the complex interplay between inflammation, eosinophil infiltration, and NSCLC prognosis among various histological subtypes. Further studies are required to underscore the role of eosinophils in NSCLC among different histological subgroups and their role in shaping the tumor microenvironment.
Collapse
Affiliation(s)
- Bilal Alashkar Alhamwe
- Institute of Laboratory Medicine, German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Medical Faculty, Philipps University of Marburg, 35043 Marburg, Germany
- Institute of Tumor Immunology, Center for Tumor Biology and Immunology, Philipps University Marburg, 35043 Marburg, Germany
- College of Pharmacy, International University for Science and Technology (IUST), Daraa 15, Syria
| | - Kadriya Yuskaeva
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Translational Research Unit (STF), Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
| | - Friederike Wulf
- Institute of Laboratory Medicine, German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Medical Faculty, Philipps University of Marburg, 35043 Marburg, Germany
| | - Frederik Trinkmann
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Department of Pneumology and Respiratory Medicine, Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
- Department of Biomedical Informatics (DBMI), Center for Preventive Medicine and Digital Health Baden-Württemberg (CPD-BW), University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, 69117 Heidelberg, Germany
| | - Mark Kriegsmann
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Institute of Pathology, University Hospital Heidelberg, Pathology Wiesbaden, Ludwig-Erhard-Str. 100, 65199 Wiesbaden, Germany
| | - Michael Thomas
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Department of Oncology, Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
| | - Corinna Ulrike Keber
- Institute for Pathology, University Hospital Giessen and Marburg, 35037 Marburg, Germany
| | - Elke Pogge von Strandmann
- Institute of Tumor Immunology, Center for Tumor Biology and Immunology, Philipps University Marburg, 35043 Marburg, Germany
| | - Felix J Herth
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Department of Pneumology and Respiratory Medicine, Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
| | - Saeed Kolahian
- Institute of Laboratory Medicine, German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Medical Faculty, Philipps University of Marburg, 35043 Marburg, Germany
| | - Harald Renz
- Institute of Laboratory Medicine, German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Medical Faculty, Philipps University of Marburg, 35043 Marburg, Germany
| | - Thomas Muley
- Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), 35394 Heidelberg, Germany
- Translational Research Unit (STF), Thoraxklinik, University Hospital Heidelberg, 69126 Heidelberg, Germany
| |
Collapse
|
2
|
The Regulatory Network of Sturgeon Chondroitin Sulfate on Colorectal Cancer Inhibition by Transcriptomic and Proteomic Analysis. Int J Mol Sci 2021; 22:ijms22179395. [PMID: 34502301 PMCID: PMC8430666 DOI: 10.3390/ijms22179395] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2021] [Revised: 08/16/2021] [Accepted: 08/20/2021] [Indexed: 12/11/2022] Open
Abstract
Chondroitin sulfate (CS) is a food-derived bioactive substance with multiple biological functions, which exists in animal cartilage and/or bone. Sturgeon, a type of cartilaginous fish, is rich in CS. Our recent study demonstrated the effect of sturgeon chondroitin sulfate (SCS) on reducing colorectal cancer cell proliferation and tumor formation. However, the molecular mechanisms of its anticancer activity remain unknown. In this study, the cell proliferation assay and flow cytometric analysis were used to examine the cell viability and apoptosis of colon cancer cell HT-29 cells and normal colonic epithelial cell NCM460 cells. Transcriptomic and proteomic studies were used to identify the main targets of SCS. SCS showed little effect on the genes/proteins expression profile of NCM460 cells but more sensitive to HT-29, in which 188 genes and 10 proteins were differentially expressed after SCS treatment. Enrichment analysis of those genes/proteins showed that the majority of them are involved in DNA replication, cell cycle progression and apoptosis. Quantitative RT-PCR and Western blot were used to determine essential genes/proteins and networks targeted by SCS to exert inhibiting the development of colorectal cancer function. This study provided great insights into developing food-derived novel therapeutics for colorectal cancer treatment.
Collapse
|